1. Home
  2. IMXI vs HUMA Comparison

IMXI vs HUMA Comparison

Compare IMXI & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo International Money Express Inc.

IMXI

International Money Express Inc.

HOLD

Current Price

$15.45

Market Cap

456.2M

Sector

Technology

ML Signal

HOLD

Logo Humacyte Inc.

HUMA

Humacyte Inc.

HOLD

Current Price

$1.30

Market Cap

236.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMXI
HUMA
Founded
1994
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
456.2M
236.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
IMXI
HUMA
Price
$15.45
$1.30
Analyst Decision
Buy
Strong Buy
Analyst Count
3
8
Target Price
$16.67
$10.13
AVG Volume (30 Days)
237.6K
4.3M
Earning Date
11-10-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.29
N/A
Revenue
$625,123,000.00
$1,571,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$0.95
$731.05
P/E Ratio
$11.97
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.58
$1.09
52 Week High
$22.30
$6.77

Technical Indicators

Market Signals
Indicator
IMXI
HUMA
Relative Strength Index (RSI) 74.34 47.73
Support Level $15.06 $1.21
Resistance Level $15.36 $1.32
Average True Range (ATR) 0.07 0.07
MACD 0.00 0.02
Stochastic Oscillator 86.67 55.88

Price Performance

Historical Comparison
IMXI
HUMA

About IMXI International Money Express Inc.

International Money Express Inc is a processor of money transfer services in the USA to the Latin America and the Caribbean (LAC) corridor. The company offers wire transfer, money order, Foreign exchange, and cash checking services, while the majority of the revenue is derived from wire transfer and money order fees. The firm's business is organized around one reportable segment that provides money remittance services between the U.S. and Canada to Mexico, Guatemala, and other countries in Latin America, Africa, and Asia.

About HUMA Humacyte Inc.

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

Share on Social Networks: